The compound does not care about muscle tissue
Regulatory Notice: As of 2023, the FDA has reclassified BPC-157 into Category 2 of the Bulk Drug Substances list, which prohibits its use in compounded medications due to a lack of long-term human safety data
When tissue is injured, fibroblasts travel to the site of the injury to facilitate the healing process.) Increases VEGF 2, which improves angiogenesis (the formation of blood vessels) and neurological remodeling
Daily administration builds and maintains peptide levels, while irregular dosing leads to inconsistent results
At Midi Health, were fielding questions every day from women who want to know which peptides are backed by science, which are overhyped, and whether they actually need them
Is the product authentic and lab-verified